Physician profile
Vikas Bhalla
NPI 1467609446
$123,349.23
in general payments reported to CMS, 2019-2025
19 companies · $2,563 in 2025
The $2,563 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $63K · 2021: $48K · 2022: $722 · 2023: $4,148 · 2024: $4,603 · 2025: $2,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,937 · Travel and Lodging: $1,704 · Consulting Fee: $1,590 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,936.51 |
| Travel and Lodging | $1,704.30 |
| Consulting Fee | $1,590.00 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $105,250.34 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $9,955.06 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Talisman, Cardiomems |
| Abiomed | $3,477.49 | 2022-2025 | Impella |
| Boston Scientific Corporation | $1,182.44 | 2020-2025 | Avvigo Guidance System, General - Balloon Catheters, Watchman Flx |
| Shockwave Medical, INC | $813.17 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $576.38 | 2019-2025 | Lifevest |
| Ekos Corporation | $383.70 | 2019 | |
| Livanova USA, INC. | $345.08 | 2020-2023 | Lifesparc |
| Cardiva Medical, INC. | $305.01 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $239.60 | 2021-2023 | Indigo System |
| Medtronic, INC. | $222.45 | 2024-2025 | Ffrangio, Micra, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $158.17 | 2025 | Camzyos, Eliquis |
| Terumo Medical Corporation | $129.38 | 2024 | Glidewire, Metacross Otw |
| Endotronix, INC. | $88.27 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $51.39 | 2021 | |
| Bard Peripheral Vascular, INC. | $47.80 | 2024 | Lifestream |
| Novartis Pharmaceuticals Corporation | $24.23 | 2023 | |
| Cardiovascular Systems INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.